BSEParmax Pharma LimitedHighNeutral
Announced Wed, 22 Jul · 13:41 IST

Open Offer at Rs 42.80 launched for 26% stake in Parmax Pharma

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹104.97
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-2.0-0.1
Up moveDown movePending
AI summary

Acquirers Dhiren Shah and Sunil Shah with 10 persons acting in concert have launched an open offer for up to 23,46,250 shares (26 percent of expanded voting capital) of Parmax Pharma from public shareholders at Rs 42.80 per share, about Rs 10.04 crores total. This follows a Share Purchase Agreement for 12.77 percent from existing promoters at Rs 35 per share. Existing promoters will fully exit, causing change of control. Tendering period runs July 30 to August 12, 2026.

Likely market impact

Public shareholders can tender shares at Rs 42.80 from July 30 to Aug 12, 2026. Change of control as existing promoters will fully exit.